Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.22 - $0.66 $5,203 - $15,609
-23,651 Reduced 50.74%
22,957 $8,000
Q3 2023

Nov 14, 2023

BUY
$0.2 - $1.78 $8,397 - $74,740
41,989 Added 909.05%
46,608 $10,000
Q2 2023

Aug 14, 2023

SELL
$1.02 - $1.89 $19,305 - $35,772
-18,927 Reduced 80.38%
4,619 $8,000
Q1 2023

May 09, 2023

BUY
$1.0 - $1.35 $15,928 - $21,502
15,928 Added 209.08%
23,546 $26,000
Q4 2022

Feb 10, 2023

SELL
$0.87 - $1.33 $29,999 - $45,861
-34,482 Reduced 81.9%
7,618 $8,000
Q3 2022

Nov 10, 2022

BUY
$1.02 - $1.26 $26,484 - $32,715
25,965 Added 160.92%
42,100 $51,000
Q2 2022

Aug 15, 2022

SELL
$0.91 - $2.01 $56,704 - $125,249
-62,313 Reduced 79.43%
16,135 $16,000
Q1 2022

May 12, 2022

BUY
$1.22 - $2.03 $66,487 - $110,630
54,498 Added 227.55%
78,448 $139,000
Q4 2021

Feb 14, 2022

BUY
$1.27 - $2.23 $5,933 - $10,418
4,672 Added 24.23%
23,950 $33,000
Q3 2021

Nov 15, 2021

BUY
$2.12 - $2.76 $37,072 - $48,264
17,487 Added 976.38%
19,278 $42,000
Q2 2021

Aug 16, 2021

SELL
$1.78 - $2.76 $40,206 - $62,342
-22,588 Reduced 92.65%
1,791 $4,000
Q1 2021

May 17, 2021

BUY
$0.94 - $3.31 $16,557 - $58,302
17,614 Added 260.37%
24,379 $55,000
Q4 2020

Feb 16, 2021

BUY
$0.7 - $1.58 $4,735 - $10,688
6,765 New
6,765 $9,000

Others Institutions Holding OTLK

About Outlook Therapeutics, Inc.


  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.17B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.